The number of people with susceptibility test result for rifampicin in Bulgaria

Bulgaria: The number of people with susceptibility test result for rifampicin was 47.71 in 2021. ▼ Falling

Latest (2021)
47.71
Change on year
down 8.5%
World rank
115th
of 146 countries
All-time high
86.7
in 2018
All-time low
47.71
in 2021
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Bulgaria, 2017–2021

0204060802017201920212017: 84.72018: 86.72019: 69.82020: 52.12021: 47.7

Source: World Health Organization, Global Health Observatory.

Analysis

Bulgaria recorded 47.71 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.

That represents a change of down 8.5% on the previous year and down 43.6% over five years.

Bulgaria ranks 115th of 146 countries on this measure, in the bottom quarter.

The number of people with susceptibility test result for rifampicin in Bulgaria, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. in Bulgaria, 2017 to 2021.
Year Value Change
2017 84.65
2018 86.7 +2.4%
2019 69.84 -19.4%
2020 52.14 -25.3%
2021 47.71 -8.5%

Bulgaria compared with similar countries

  • Bulgaria's 47.71 is below the median for high income countries, which is 92.6, 52% of the median. (56 countries reporting)
  • Bulgaria's 47.71 is below the median for Europe & Central Asia, which is 93.52, 51% of the median. (43 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 80.4 69.84 86.7 3
2020s 49.92 47.71 52.14 2

Countries ranked near Bulgaria

  1. 112 Portugal 54.52 compare
  2. 113 Equatorial Guinea 54.36 compare
  3. 114 Brazil 50.47 compare
  4. 116 Iran, Islamic Republic of 46.76 compare
  5. 117 Nicaragua 46.72 compare
  6. 118 Solomon Islands 45.52 compare

See the full ranking of 148 places →

More health data for Bulgaria

All data for Bulgaria →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Bulgaria?
The number of people with susceptibility test result for rifampicin in Bulgaria was 47.71 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Bulgaria?
The highest recorded value was 86.7 in 2018.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Bulgaria?
The lowest recorded value was 47.71 in 2021.
How does Bulgaria rank for the number of people with susceptibility test result for rifampicin?
Bulgaria ranks 115th out of 146 countries with data for 2021.
Where does this Bulgaria data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Bulgaria. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/bulgaria/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/bulgaria/">The number of people with susceptibility test result for rifampicin in Bulgaria</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed